These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3097715)

  • 1. Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment.
    Pisani F; Fazio A; Spina E; Artesi C; Pisani B; Russo M; Trio R; Perucca E
    Psychopharmacology (Berl); 1986; 90(3):295-8. PubMed ID: 3097715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implications.
    Altamura AC; Melorio T; Invernizzi G; Colacurcio F; Gomeni R
    Psychopharmacology (Berl); 1983; 81(4):281-5. PubMed ID: 6419255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of viloxazine hydrochloride in man.
    Vandel B; Vandel S; Jounet JM; Blum D
    Eur J Drug Metab Pharmacokinet; 1982; 7(1):65-8. PubMed ID: 7067726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Artesi C; Xiao B; Perucca E; Di Perri R
    Acta Neurol Scand; 1994 Aug; 90(2):130-2. PubMed ID: 7801739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood level studies with viloxazine hydrochloride in man.
    Bayliss PF; Case DE
    Br J Clin Pharmacol; 1975 Jun; 2(3):209-14. PubMed ID: 1234502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine-viloxazine interaction in patients with epilepsy.
    Pisani F; Fazio A; Oteri G; Perucca E; Russo M; Trio R; Pisani B; Di Perri R
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1142-5. PubMed ID: 3783175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of phenobarbital in normal subjects and epileptic patients.
    Wilensky AJ; Friel PN; Levy RH; Comfort CP; Kaluzny SP
    Eur J Clin Pharmacol; 1982; 23(1):87-92. PubMed ID: 7128675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: pharmacological and pharmacokinetic studies in rodents and the epileptic baboon.
    Meldrum BS; Anlezark GM; Adam HK; Greenwood DT
    Psychopharmacology (Berl); 1982; 76(3):212-7. PubMed ID: 6808538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of viloxazine on serum carbamazepine levels in epileptic patients.
    Pisani F; Narbone MC; Fazio A; Crisafulli P; Primerano G; D'Agostino AA; Oteri G; Di Perri R
    Epilepsia; 1984 Aug; 25(4):482-5. PubMed ID: 6745218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients.
    Giaccone M; Bartoli A; Gatti G; Marchiselli R; Pisani F; Latella MA; Perucca E
    Br J Clin Pharmacol; 1996 Jun; 41(6):575-9. PubMed ID: 8799524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between blood and cerebrospinal levels of the antidepressant agent viloxazine.
    Elwan O; Adam HK
    Eur J Clin Pharmacol; 1980; 17(3):179-82. PubMed ID: 7363931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy.
    Eichelbaum M; Köthe KW; Hoffman F; von Unruh GE
    Clin Pharmacol Ther; 1979 Sep; 26(3):366-71. PubMed ID: 466929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choosing an antidepressant.
    Case DE
    Br Med J; 1978 May; 1(6122):1281. PubMed ID: 647235
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of phenylethylmalonamide (PEMA) in normal subjects and in patients treated with antiepileptic drugs.
    Cottrell PR; Streete JM; Berry DJ; Schäfer H; Pisani F; Perucca E; Richens A
    Epilepsia; 1982 Jun; 23(3):307-13. PubMed ID: 7084140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of anticonvulsants.
    Hvidberg EF; Dam M
    Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ
    Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of sodium valproate in epileptic patients.
    Perucca E; Gatti G; Frigo GM; Crema A; Calzetti S; Visintini D
    Br J Clin Pharmacol; 1978 Jun; 5(6):495-9. PubMed ID: 350251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.
    Pisani F; Fazio A; Artesi C; Russo M; Trio R; Oteri G; Perucca E; Di Perri R
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):126-7. PubMed ID: 1538217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.